Predict your next investment

Corporation
HEALTHCARE | Biotechnology
fluidigm.com

See what CB Insights has to offer

Founded Year

1999

Stage

IPO | IPO

Total Raised

$142.7M

Date of IPO

2/10/2011

Market Cap

0.36B

Stock Price

4.69

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets microfluidic systems to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Fluidigm's proprietary microfluidic systems consist of instruments and consumables, including 18 different commercial integrated fluidic circuits for nucleic acid analysis, and three families of assay chemistries. These systems are designed to significantly simplify experimental workflow, increase throughput, and reduce costs, while providing the excellent data quality demanded by customers.

Fluidigm Headquarter Location

7000 Shoreline Court Suite 100

South San Francisco, California, 94080,

United States

650-266-6000

Latest Fluidigm News

Worldwide Sequencing Reagents Industry To 2028 - Focus On Oncology, Clinical Investigation, Agri Genomics & Forensics And Reproductive Health

Nov 22, 2021

Nov 22, 2021 6:00 AM EST Worldwide Sequencing Reagents Industry To 2028 - Focus On Oncology, Clinical Investigation, Agri Genomics & Forensics And Reproductive Health DUBLIN, Nov. 22, 2021 /PRNewswire/ -- The "Global Sequencing Reagents Market 2021-2028" report has been added to ResearchAndMarkets. Author: DUBLIN, Nov. 22, 2021 /PRNewswire/ -- The "Global Sequencing Reagents Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. According to this report, the global sequencing reagents market is assessed to observe a growth trend at a CAGR of 12.83% based on revenue through the considered period 2021-2028.The ongoing research in genomics due to the rise in chronic diseases, along with the advancement in genomics following the launch of new technologies, are driving the studied market on a growth path. Additionally, investments by manufacturers and governments in genomics are opening new avenues for the market globally.Conversely, social and ethical issues relating to data privacy and the lack of professionals in developing regions impede the overall growth of the sequencing reagents market. Regional Outlook The global sequencing reagents market comprises the Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.Geographically, the Asia-Pacific is estimated to emerge as the fastest evolving region in the sequencing reagents market over the reviewed period. The region's robust growth can be attributed to the surging investments by government bodies across the major countries. Moreover, the increase in research and development of genomics is another factor contributing to the studied market's growth. For instance, the Indian government has introduced initiatives for startups in the biotechnology sector, which will ultimately foster the growth of the sequencing reagents market. Competitive Outlook The key companies thriving in the sequencing reagents market are F Hoffmann La Roche, Illumina Inc, Perkinelmer Inc, Qiagen NV, Bio Rad Laboratories Inc, Trilink Biotechnologies Inc, Asuragen Inc, Merck KGAA, Agilent Technologies Inc, BGI Genomics, Thermo Fisher Scientific Inc, Fluidigm Corporation, Pacific Biosciences of California Inc, Takara Bio Inc, and LGC Biosearch Technologies.Thermo Fisher Scientific Inc is a leading company operating under various business segments, such as laboratory products & services, analytical instruments, specialty diagnostics, and life sciences solutions. It develops and delivers its products to research institutes, government agencies, universities, hospitals, and pharmaceutical companies, among others. Founded in 2006, Thermo Fisher has a presence across more than 50 nations. It is headquartered in Massachusetts, the United States. Key Topics Covered: 1. Global Sequencing Reagents Market - Summary 2. Industry Outlook2.1. Impact of Covid-19 on Sequencing Reagents Market2.2. Key Insights2.3. Porter's Five Forces Model2.3.1. Threat of New Entrants2.3.2. Threat of Substitute Products2.3.3. Bargaining Power of Buyers2.3.4. Bargaining Power of Suppliers2.3.5. Competitive Rivalry2.4. Supply Chain Outlook2.5. Market Attractiveness Index2.6. Vendor Scorecard2.7. Key Strategic Developments2.7.1. Contracts and Partnerships2.7.2. Business Expansions, Announcements, and Divestitures2.7.3. Acquisitions & Mergers2.7.4. New Product Launches & Developments2.8. Market Drivers2.8.1. Ongoing Research in Genomics Due to the Prevalence of Chronic Diseases2.8.2. Advances in Genomics After the Launch of New Technologies2.9. Market Challenges2.9.1. Social and Ethical Issues Related to Data Privacy2.9.2. Lack of Professionals in Developing Countries2.10. Market Opportunities2.10.1. Funding by Manufacturers and Government in Genomics2.10.2. Growing Demand for Third-Generation Sequencing 3. Global Sequencing Reagents Market - by Application3.1. Oncology3.2. Clinical Investigation3.3. Agri Genomics and Forensics3.4. Reproductive Health3.5. Other Applications 4. Global Sequencing Reagents Market - by Reagent Type4.1. Sequencing Kits4.2. Control Kits4.3. Library Kits4.4. Template Kits4.5. Other Reagent Types 5. Global Sequencing Reagents Market - by Technology5.1. Next-Generation Sequencing5.2. Sanger Sequencing5.3. Third-Generation Sequencing 6. Global Sequencing Reagents Market - by Industry Verticals6.1. Research Institutes6.2. Hospitals and Clinics6.3. Pharmaceutical and Biotechnology Companies6.4. Other Industry Verticals 7. Global Sequencing Reagents Market - Regional Outlook 8. Company Profile8.1. Agilent Technologies Inc8.2. Asuragen Inc8.3. Bgi Genomics8.4. Bio Rad Laboratories Inc8.5. F Hoffmann La Roche8.6. Fluidigm Corporation8.7. Illumina Inc8.8. Lgc Biosearch Technologies8.9. Merck Kgaa8.10. Pacific Biosciences of California Inc8.11. Perkinelmer Inc8.12. Qiagen Nv8.13. Takara Bio Inc8.14. Thermo Fisher Scientific Inc8.15. Trilink Biotechnologies Inc 9. Research Methodology & Scope9.1. Research Scope & Deliverables9.1.1. Objectives of Study9.1.2. Scope of Study9.2. Sources of Data9.2.1. Primary Data Sources9.2.2. Secondary Data Sources9.3. Research Methodology9.3.1. Evaluation of Proposed Market9.3.2. Identification of Data Sources9.3.3. Assessment of Market Determinants9.3.4. Data Collection9.3.5. Data Validation & Analysis For more information about this report visit https://www.researchandmarkets.com/r/rxkair Media Contact: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com    For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 View original content: https://www.prnewswire.com/news-releases/worldwide-sequencing-reagents-industry-to-2028---focus-on-oncology-clinical-investigation-agri-genomics--forensics-and-reproductive-health-301429769.html

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Fluidigm

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Fluidigm is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Fluidigm Patents

Fluidigm has filed 129 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Mass spectrometry
  • Biotechnology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/16/2016

9/14/2021

Molecular biology, Biotechnology, DNA, Molecular biology techniques, Genetics

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/16/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/14/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Biotechnology, DNA, Molecular biology techniques, Genetics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Fluidigm Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Fluidigm Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.